Radiotherapy plus temozolomide in elderly patients with glioblastoma: a “real-life” report

Radiotherapy plus temozolomide in elderly patients with glioblastoma: a “real-life” report

Abstract Background The optimization of the management for elderly glioblastoma patients is crucial given the demographics of aging in many countries. We report the outcomes for a “real-life” patient cohort (i.e. unselected) comprising consecutive glioblastoma patients aged 70 years or more, treated...

Full description

Bibliographic Details
Main Authors: J. Biau, E. Chautard, E. De Schlichting, G. Dupic, B. Pereira, A. Fogli, M. Müller-Barthélémy, P. Dalloz, T. Khalil, A. F. Dillies, X. Durando, C. Godfraind, P. Verrelle
Format: Article
Language:English
Published: BMC 2017-12-01
Series:Radiation Oncology
Subjects:
Elderly
Glioblatoma
Temozolomide
Hypofractionated radiotherapy
Online Access:http://link.springer.com/article/10.1186/s13014-017-0929-2

Internet

http://link.springer.com/article/10.1186/s13014-017-0929-2

Similar Items